FDS 137.76 Factset Research Systems Inc $FDS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
FDS 137.76 Factset Research Systems Inc $FDS Hit a 52 week high of 137.96 Closing the day 09:45 at 137.76 +0.26 +0.19% With a day low of 137.14 and a total volume of 5,189.

FDS Recent Posts: http://investorshangout.com/FactSet-Research-...FDS-50984/

FDS Factset Research Systems Inc Recent Headline News

FactSet Research Systems declares $0.39 dividend
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 7:54AM CST

FDS: 137.86 (+0.36)

FactSet Research Systems Declares Dividend
GlobeNewswire - Wed Nov 12, 6:00AM CST
FactSet Research Systems Inc. (NYSE:FDS) (Nasdaq:FDS), a leading provider of integrated global financial information and analytical applications for the investment community, today announced that its Board of Directors approved a regular quarterly dividend of $0.39 per share. The cash dividend will be paid on December 16, 2014 to holders of record of FactSet's common stock at the close of business on November 28, 2014.
FDS: 137.86 (+0.36)

Geographic Revenue Exposure Data Now Available in FactSet Portfolio Analytics
GlobeNewswire - Thu Nov 06, 9:30AM CST
FactSet Research Systems Inc. (NYSE:FDS) (Nasdaq:FDS), a leading provider of financial information and analytical applications to the global investment community, today announced the release of the FactSet Geographic Revenue Exposure (GeoRevs) data within the FactSet Portfolio Analytics product to give investors a better way to uncover risk and fine-tune exposures.
FDS: 137.86 (+0.36)

Insider Trading Alert - FDS, BGS And MSI Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include FDS, BGS and MSI
MSI: 64.38 (+0.68), BGS: 29.47 (+0.02), FDS: 137.86 (+0.36)

McGraw Hill Q3 Earnings Beat, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:52AM CDT
McGraw Hill Financial, Inc's (MHFI) third-quarter 2014 adjusted earnings of $1.02 per share beat the Zacks Consensus Estimate but revenues of $1,263 million failed to meet expectations.
DNB: 125.01 (unch), MHFI: 90.65 (+0.14), FDS: 137.86 (+0.36), MCO: 100.63 (+0.55)

Stock Market News for October 21, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 9:10AM CDT
Dismal earnings result from IBM offset benchmarks’ gains yesterday, which nonetheless finished in the green
DHI: 24.33 (+0.32), QEPM: 15.77 (+0.06), HAS: 54.43 (-3.04), LEN: 45.74 (+0.18), QEP: 23.79 (-0.68), TSO: 71.88 (-0.96), IBM: 162.32 (+0.40), GCI: 30.95 (+0.08), PHM: 20.84 (+0.15), HAL: 51.42 (-1.81), TLLP: 57.39 (+0.14), TOL: 33.81 (+0.30), FDS: 137.86 (+0.36)

Shareholders Turn Their Attention to Golden Parachutes and Political Contributions While More Companies Implement Winning Governance Proposals, The Conference Board Reports
PR Newswire - Thu Sep 18, 9:00AM CDT
Research released today by The Conference Board in collaboration with FactSet reconstructs how shareholder activism and voting at annual general meetings (AGMs) of U.S. public companies have evolved in the last five years. The report, Proxy Voting Analytics (2010-2014), examines data from more than 2,500 AGMs held at Russell 3000 companies between January 1 and June 30. It shows a fundamental shift in the types of resolutions submitted to a vote by shareholders, the sophistication developed by activist investors in the use of technology and social media to agitate for corporate change outside of the AGM, and the increased propensity of senior management to implement precatory shareholder proposals on corporate governance that have received the support of a majority of voting shares.
FDS: 137.86 (+0.36)

Why FactSet (FDS) Stock Is Down Today
at The Street - Wed Sep 17, 10:37AM CDT
Shares of FactSet Research Systems (FDS) are falling after Piper Jaffray (PJC) downgraded the company to 'neutral' from 'overweight' with a price target of $130.
FDS: 137.86 (+0.36)

Shares of FDS Up 9.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Sep 17, 9:55AM CDT
SmarTrend identified an Uptrend for Factset Research Systems (NYSE:FDS) on March 18th, 2014 at $112.51. In approximately 6 months, Factset Research Systems has returned 9.89% as of today's recent price of $123.64.
FDS: 137.86 (+0.36)

Company News for September 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 9:10AM CDT
Companies in the News are: GRT,ALOG,DKS,FDS
DKS: 47.07 (-1.51), ALOG: 72.39 (-0.44), GRT: 13.86 (+0.05), FDS: 137.86 (+0.36)

FactSet Research Systems (FDS) Is Today's Water-Logged And Getting Wetter Stock
at The Street - Wed Sep 17, 9:00AM CDT
Trade-Ideas LLC identified FactSet Research Systems (FDS) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
FDS: 137.86 (+0.36)

FactSet Q4 Earnings In Line, Revenues Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 17, 8:10AM CDT
FactSet Research Systems Inc. (FDS) reported fourth-quarter fiscal 2014 earnings per share of $1.31, which came in line with the Zacks Consensus Estimate.
MU: 33.02 (+0.11), MSCI: 47.92 (-0.11), EFX: 78.36 (-0.29), FDS: 137.86 (+0.36)

Downgrade Alert for Factset Research Systems (FDS)
Comtex SmarTrend(R) - Wed Sep 17, 6:54AM CDT
Factset Research Systems (NYSE:FDS) was downgraded from Overweight to Neutral at Piper Jaffray today. The stock closed yesterday at $126.76 on volume of 582,000 shares, above average daily volume of 246,000. In the past 52 weeks, shares of Factset Research Systems have traded between a low of $101.41 and a high of $129.75 and closed yesterday at $126.76, which is 25% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.3%.
FDS: 137.86 (+0.36)

FactSet beats Q4 EPS views
at Investor's Business Daily - Tue Sep 16, 5:49PM CDT
Per-share earnings of the financial information service company grew 11% to $1.31 in Q4, topping Thomson Reuters' views by a penny. Revenue rose 9% to $238.7 mil, beating forecasts for $236.9 mil. FactSet (FDS) expects Q1 '15 revenue of $240 mil-$243...
FDS: 137.86 (+0.36)

FactSet Q4 EPS, Revenue Beat Street, But Shares Down
at Investor's Business Daily - Tue Sep 16, 12:00PM CDT
The financial information service FactSet reported fourth-quarter earnings and revenue results that even its rival says edged past Wall Street expectations. FactSet (FDS) earned $1.31 a share on an adjusted basis, an 11% rise from the prior-year...
TRI: 38.16 (-0.08), FDS: 137.86 (+0.36)

FactSet Sets Itself Up For a Good Year
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Tue Sep 16, 10:20AM CDT
Financial data and software provider FactSet Research Systems announced its fiscal fourth quarter results this morning. There are no major surprises and that's rather a good thing – a reflection of its high-quality, "steady-as-she-goes" business...
FDS: 137.86 (+0.36)

Will FactSet Research Systems (FDS) Stock Be Helped By This Earnings Beat?
at The Street - Tue Sep 16, 10:10AM CDT
FactSet Research Systems (FDS) shares are down despite matching and beating analysts earnings and revenue expectations.
FDS: 137.86 (+0.36)

FactSet Research Systems Reports Results for the Fourth Quarter of Fiscal 2014
GlobeNewswire - Tue Sep 16, 6:00AM CDT
-- ASV increased $31.6 million, up 7.3% organically
FDS: 137.86 (+0.36)

Will FactSet Research (FDS) Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 8:30AM CDT
FactSet Research Systems Inc. (FDS) is set to report fiscal fourth-quarter 2014 results on Sep 16, 2014.
MU: 33.02 (+0.11), MSCI: 47.92 (-0.11), BBRY: 11.45 (+0.18), FDS: 137.86 (+0.36)

ADBE, FDS and APOG Earnings Reports Potentially Impacted by Research Linking Stock Price and HR Metrics
M2 - Mon Sep 15, 3:54AM CDT
September 16, 2014 - The Human Capital Management Institute (HCMI), an industry leader in predictive human capital management metrics and advanced workforce analytics solutions, released research showing that profit and revenue don't actually predict stock price, but some other, little-used metrics do (http://hcminst.com/linking-human-capital-to-business-performance). The study, performed by Jeff Higgins, CEO of the Human Capital Management Institute, and Pepperdine University professor Donald Atwater, shows that human capital contributions to stock performance are clearly linked. According to the model, a 10% increase in human capital productivity metrics are associated with stock price gains of -.7% to 29% by sector. Human capital metrics are significant in all sectors explaining 35% to 64% of rate of change in stock prices, far more than the average 1% explained by net income.
APOG: 44.23 (-0.58), ADBE: 71.71 (+0.30), FDS: 137.86 (+0.36)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 69

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 80

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 18

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading

Top 5 Most Recently Viewed Articles

Rockpool Acquisitions Faces Trading Suspension from FCA

Updated Category News Views 230

Trading Suspension of Rockpool Acquisitions Plc Shares LONDON - Recently, the Financial Conduct Authority (FCA) announced an immediate suspension of Rockpool Acquisitions Plc's ordinary shares from the Official List. The suspension was requested by the company itself and serves to protect the interests of investors and maintain market integrity. Details of the Suspension...

Continue Reading
Discover the Growth of Linde Stock Over the Past Decade

Updated Category News Views 262

Linde Stock Performance: A Decade in Review Linde (NASDAQ: LIN) has exhibited exceptional performance in the stock market over the past ten years, showcasing an impressive annualized return of 13.72%. This growth has outpaced the overall market by 2.12%, demonstrating the strength of Linde's business strategies and market presence. Investment Growth Over Ten Years If an...

Continue Reading
Exploring Saudi Arabia's Economic Growth Trends in Q3

Updated Category News Views 377

Saudi Arabia's Economic Overview in Q3 In a remarkable turn of events, Saudi Arabia's economy has reported a year-over-year growth of 2.8% for the third quarter. This growth, as unveiled by preliminary government statistics, has been largely fueled by robust performance in non-oil sectors, indicating a diversification effort from the nation. This positive trend is a...

Continue Reading
ANTHBOT's Quiet Drive Mirrors Athlete's Steadfastness

Updated Category News Views 4

Unveiling Consistent Performance Just like a goalkeeper defends the goal, ANTHBOT defends your lawn—silently and consistently. Partnering up with German goalkeeper Marc ter Stegen in their latest campaign, ANTHBOT is airing a TV blitz across ARD, ZDF, and digital platforms. This ain't just some ad blitz; it's a thoughtful nudge toward understanding how regular, quiet,...

Continue Reading
WisdomTree Earns 2024 Best Places to Work Honors Again

Updated Category News Views 162

WisdomTree Achieves Recognition in Employee Satisfaction WisdomTree, Inc. (NYSE: WT), known for its pioneering approach in the finance sector, has been celebrating another significant achievement. Recognized as a 2024 Best Places to Work in Money Management, this marks the fifth consecutive year the company has attained this honor. The accolades stem from a robust survey...

Continue Reading